Cross-sectional and longitudinal associations between cardiometabolic measures and clinical stage in young people accessing early intervention mental health services.

Autor: Wilson CE; Brain and Mind Centre, Youth Mental Health and Technology Team, The University of Sydney, Camperdown, Australia., Carpenter JS; Brain and Mind Centre, Youth Mental Health and Technology Team, The University of Sydney, Camperdown, Australia., Crouse JJ; Brain and Mind Centre, Youth Mental Health and Technology Team, The University of Sydney, Camperdown, Australia., Park S; Brain and Mind Centre, Youth Mental Health and Technology Team, The University of Sydney, Camperdown, Australia., Koethe D; Brain and Mind Centre, Youth Mental Health and Technology Team, The University of Sydney, Camperdown, Australia., Scott EM; Brain and Mind Centre, Youth Mental Health and Technology Team, The University of Sydney, Camperdown, Australia., Hickie IB; Brain and Mind Centre, Youth Mental Health and Technology Team, The University of Sydney, Camperdown, Australia.
Jazyk: angličtina
Zdroj: Early intervention in psychiatry [Early Interv Psychiatry] 2023 Sep; Vol. 17 (9), pp. 893-900. Date of Electronic Publication: 2023 Jan 22.
DOI: 10.1111/eip.13381
Abstrakt: Aim: This retrospective cohort study aimed to identify the cardiometabolic characteristics, cross-sectionally and longitudinally, associated with clinical stage in youth accessing early intervention mental health services.
Methods: Cardiometabolic data we collected in 511 young people (aged 12-25 years at entry) receiving mental health care at the early intervention services in Sydney, Australia.
Results: The majority of young people (N = 448, 87.67%) were classified in stage 1a or 1b at entry. At entry to care, there was no cross-sectional relationship between clinical stage and age, gender, fasting insulin, fasting glucose, updated homeostatic model assessment for insulin resistance (HOMA2-IR) score, BMI or waist circumference. Of the 111 (21.7%) young people initially classified at stage 1a ('non-specific symptoms') and the 337 (65.9%) classified in stage 1b ('attenuated syndromes'), 40 individuals transitioned to stage 2+ (7.8%) ("full-threshold disorders") longitudinally. No cardiometabolic factors predicted clinical stage transitions. However, those with an increase in BMI over the course of care (n = 54) were 1.46 (OR; 95% CI: 1.02-2.17) times more likely to progress to stage 2+ at follow up.
Conclusions: Whilst no relationships were found between demographic or cardiometabolic variables and clinical stage at entry to care, an increased BMI over time was associated with clinical stage transition longitudinally. Further longitudinal research is needed to understand the demographic, clinical, illness progression or treatment factors associated with changes in cardiometabolic status.
(© 2023 The Authors. Early Intervention in Psychiatry published by John Wiley & Sons Australia, Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje